Pfizer and BioNTech’s favored Covid-19 vaccine has fewer side effects than their first

by Raphael Stevens 21 August 2020, 00:17 159 Views

Pfizer and BioNTech surprised many industry watchers on July 27 when they announced they would conduct a large-scale study of a vaccine for Covid-19. The surprise? The vaccine that would be tested in a 30,000-patient trial wasn’t the one for which the companies had presented data on July 1.

Source: Business - cnbc.com

U.S. economic recovery outlook steady even as Wall St touches record: Reuters Poll

5 National Currencies That Bitcoin Is Absolutely Crushing in 2020

This portal is not a newspaper as it is updated without periodicity. It cannot be considered an editorial product pursuant to law n. 62 of 7.03.2001. The author of the portal is not responsible for the content of comments to posts, the content of the linked sites. Some texts or images included in this portal are taken from the internet and, therefore, considered to be in the public domain; if their publication is violated, the copyright will be promptly communicated via e-mail. They will be immediately removed.

Pfizer and BioNTech’s favored Covid-19 vaccine has fewer side effects than their first

U.S. economic recovery outlook steady even as Wall St touches record: Reuters Poll

5 National Currencies That Bitcoin Is Absolutely Crushing in 2020

ITALIAN LANGUAGE

ENGLISH LANGUAGE